Article

Smart designing of new hybrid materials based on brushite-alginate and monetite-alginate microspheres: Bio-inspired for sequential nucleation and growth

Materials Science and Engineering C 01/2013; DOI: 10.1016/j.msec.2013.11.012

ABSTRACT In this report new hybrid materials based on brushite-alginate and monetite-alginate were prepared by self-assembling alginate chains and phosphate source ions via a gelation process with calcium ions. The alginate served as nanoreactor for nucleation and growth of brushite or/and monetite due to its gelling and swelling properties. The alginate gel framework, the crystalline phase and morphology of formed hybrid biomaterials were shown to be strongly dependent upon the concentration of the phosphate precursors. These materials were characterized by thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive x-ray analysis (EDX).

1 Bookmark
 · 
66 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Crystalline brushite, CaHPO4·2H2O, has been identified in embryonic chick bone by X-ray and electron diffraction. This was accomplished by independent analyses of bone powder fractions of varying density and therefore of varying degrees of mineralization. Although it was not detected in samples of whole bone powder by X-ray diffraction, brushite was found to be the major crystalline solid phase of calcium phosphate in the lowest density fractions corresponding to the least mineralized bone. Thus brushite appears to be a component of the earliest solid mineral phase deposited in bone tissue. Both brushite and hydroxyapatite were detected in fractions of bone powder of somewhat higher density, but only hydroxyapatite was present in the highest density fractions corresponding to the most highly mineralized portions of bone tissue. Electron diffraction of the unembedded, lowest density fractions of bone powder confirmed the presence of brushite. The relative Ca/P ratio of these early mineral deposits determined by electron probe microanalysis was also consistent with that of brushite. Most importantly, when either synthetic crystalline brushite or the lowest density bone powder was embedded in epoxy and thin-sectioned, no electron diffraction pattern of brushite or monetite was obtained. This result may explain why brushite has not been previously detected by electron diffraction of thin sections containing the mineral phase of bone even though such sections contain the newly deposited solid phase of Ca-P.
    Journal of Ultrastructure Research 10/1979; 68(3):235-55.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Preparation of hydroxyapatite was carried out by a homogeneous precipitation technique using hydrothermal reactions of Ca(EDTA)2- and PO4(3-) at 130-250 degrees C and pH 4-10. Hydroxyapatite and monetite were formed above pH 6 and below pH 4, respectively. Needle-like hydroxyapatite was formed at high temperatures above 130 degrees C. The length of the needle-like hydroxyapatite crystal increased with increasing working solution pH and temperature.
    Journal of Chemical Technology & Biotechnology 02/1993; 57(4):349-53. · 2.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The insulin-bearing aquasomes were fabricated by first preparing the nanosize calcium phosphate dihydrate core. The calcium phosphate dihydrate core was prepared by colloidal precipitation and sonication of disodium hydrogen phosphate solution and calcium chloride solution at low temperature. This core was coated with cellobiose, pyridoxal-5-phosphate, or trehalose under sonication and was further loaded with the drug at low temperature by a partial adsorption mechanism. The prepared systems were characterized for size, shape, size distribution, drug loading efficiency, and in vivo performance. The in vivo performance of the formulated aquasome was compared with standard porcine insulin solution, and better results were observed compared to insulin solution.
    Drug Development and Industrial Pharmacy 05/2000; 26(4):459-63. · 1.54 Impact Factor

Full-text

View
141 Downloads
Available from
May 20, 2014